株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

モノクローナル抗体治療薬市場:用途別(癌、自己免疫疾患、感染症、血液疾患、その他)、ソース別、エンドユーザー別:世界の業界見通し、包括的分析、予測

Monoclonal Antibody Therapeutics Market by Application (Cancer, Autoimmune Diseases, Infection, Hematological Diseases, and Others), By Source and By End Users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023

発行 Zion Market Research 商品コード 680079
出版日 ページ情報 英文 110 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.56円で換算しております。
Back to Top
モノクローナル抗体治療薬市場:用途別(癌、自己免疫疾患、感染症、血液疾患、その他)、ソース別、エンドユーザー別:世界の業界見通し、包括的分析、予測 Monoclonal Antibody Therapeutics Market by Application (Cancer, Autoimmune Diseases, Infection, Hematological Diseases, and Others), By Source and By End Users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023
出版日: 2018年04月09日 ページ情報: 英文 110 Pages
概要

当レポートでは、世界のモノクローナル抗体治療薬市場について調査し、市場の現状と今後の成長予測、用途別、ソース別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場動向

  • イントロダクション
  • 市場促進因子
  • 市場阻害因子
  • 機会
  • ポーターズファイブフォース分析
  • 市場の魅力度分析

第4章 競合環境

  • 企業市場シェア分析
  • 戦略的発展
  • 価格動向分析

第5章 用途別概要

  • 概要
  • 自己免疫疾患
  • 感染症
  • 血液疾患
  • その他

第6章 ソース別概要

  • 概要
  • ヒト
  • ヒト化
  • キメラ
  • その他

第7章 エンドユーザー別セグメント分析

  • 概要
  • 病院
  • 民間クリニック
  • 研究機関

第8章 地域別セグメント分析

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 企業プロファイル

目次

The report covers forecast and analysis for the monoclonal antibody therapeutics market on a global and regional level. The study provides historic data of 2015 to 2017 along with a forecast from 2018 to 2023 based on revenue (USD Billion). The study includes drivers and restraints for the monoclonal antibody therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the monoclonal antibody therapeutics market on a global level.

In order to give the users of this report a comprehensive view on the monoclonal antibody therapeutics market, we have included a competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new product launch, agreements, partnerships, collaborations joint ventures, research development, product and regional expansion of major participants involved in the market.

The study provides a decisive view on the monoclonal antibody therapeutics market by segmenting the market based on application, source, end user and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2023. Based on application, the market is segmented into cancer, autoimmune diseases, infection, hematological diseases, and others. By source, the market is segmented into human, humanized, chimeric and others. Based on end users, the market is segmented into hospitals, private clinics and research institutes. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East Africa with its further bifurcation into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for monoclonal antibody therapeutics market based on all segments in all the regions and countries.

The report also includes detailed profiles of end players such as Pfizer Inc., Bayer AG, Sanofi, Merck Co., Inc., GlaxoSmithKline Plc., F. Hoffmann-La Roche Ltd., Novartis AG, and AbbVie Inc.

This report segments the global monoclonal antibody therapeutics market as follows:

Global Monoclonal Antibody Therapeutics Market: Application Segment Analysis

  • Cancer
  • Autoimmune Diseases
  • Infection
  • Hematological Diseases
  • Others

Global Monoclonal Antibody Therapeutics Market: Source Segment Analysis

  • Human
  • Humanized
  • Chimeric
  • Others

Global Monoclonal Antibody Therapeutics Market: End User Segment Analysis

  • Hospitals
  • Private Clinics
  • Research Institute

Global Monoclonal Antibody Therapeutics Market: Regional Segment Analysis

  • North America
  • U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa

Table Of Contents

Chapter 1. Introduction

  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

Chapter 2. Executive Summary

  • 2.1. Global Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
  • 2.2. Global Monoclonal Antibody Therapeutics Market: Snapshot

Chapter 3. Monoclonal Antibody Therapeutics Market- Market Dynamics

  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Global Monoclonal Antibody Therapeutics Market Drivers: Impact Analysis
    • 3.2.2. Growing Monoclonal Antibody Therapeutics Consumption in Developing Countries
    • 3.2.3. Changing Consumption Habits of Monoclonal Antibody Therapeutics
  • 3.3. Market Restraints
    • 3.3.1. Global Monoclonal Antibody Therapeutics Market Restraints: Impact Analysis
    • 3.3.2. High Taxation in Monoclonal Antibody Therapeutics Business and Trade
  • 3.4. Opportunities
    • 3.4.1. Innovative Products with Flavored Monoclonal Antibody Therapeutics
  • 3.5. Porters Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat from New Entrants
    • 3.5.4. Threat from New Substitutes
    • 3.5.5. Degree of Competition
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market Attractiveness Analysis, by Application Segment
    • 3.6.2. Market Attractiveness Analysis, by Source Segment
    • 3.6.3. Market Attractiveness Analysis, by End User Segment
    • 3.6.4. Market Attractiveness Analysis, by Regional Segment

Chapter 4. Global Monoclonal Antibody Therapeutics Market- Competitive Landscape

  • 4.1. Company Market Share Analysis
    • 4.1.1. Global Monoclonal Antibody Therapeutics Market: Company Market Share, 2017
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions Mergers
    • 4.2.2. New Product Launch
    • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
    • 4.2.4. Research and Development and Regional Expansion
  • 4.3. Price Trend Analysis

Chapter 5. Global Monoclonal Antibody Therapeutics Market- Application Segment Analysis

  • 5.1. Global Monoclonal Antibody Therapeutics Market: Application Overview
    • 5.1.1. Global Monoclonal Antibody Therapeutics Market Revenue Share, by Application, 2017 and 2023
  • 5.2. Cancer
    • 5.2.1. Global Monoclonal Antibody Therapeutics Market for Cancer, 2015 - 2023 (USD Billion)
  • 5.3. Autoimmune Diseases
    • 5.3.1. Global Monoclonal Antibody Therapeutics Market for Autoimmune Diseases, 2015 - 2023 (USD Billion)
  • 5.4. Infection
    • 5.4.1. Global Monoclonal Antibody Therapeutics Market for Infection, 2015 - 2023 (USD Billion)
  • 5.5. Hematological Diseases
    • 5.5.1. Global Monoclonal Antibody Therapeutics Market for Hematological Diseases, 2015 - 2023 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Monoclonal Antibody Therapeutics Market for Others, 2015 - 2023 (USD Billion)

Chapter 6. Global Monoclonal Antibody Therapeutics Market- Source Segment Analysis

  • 6.1. Global Monoclonal Antibody Therapeutics Market: Source Overview
    • 6.1.1. Global Monoclonal Antibody Therapeutics Market Revenue Share, by Source, 2017 and 2023
  • 6.2. Human
    • 6.2.1. Global Monoclonal Antibody Therapeutics Market for Human, 2015 - 2023 (USD Billion)
  • 6.3. Humanized
    • 6.3.1. Global Monoclonal Antibody Therapeutics Market for Humanized, 2015 - 2023 (USD Billion)
  • 6.4. Chimeric
    • 6.4.1. Global Monoclonal Antibody Therapeutics Market for Chimeric, 2015 - 2023 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Monoclonal Antibody Therapeutics Market for Others, 2015 - 2023 (USD Billion)

Chapter 7. Global Monoclonal Antibody Therapeutics Market- End User Segment Analysis

  • 7.1. Global Monoclonal Antibody Therapeutics Market: End User Overview
    • 7.1.1. Global Monoclonal Antibody Therapeutics Market Revenue Share, by End User, 2017 and 2023
  • 7.2. Hospitals
    • 7.2.1. Global Monoclonal Antibody Therapeutics Market for Hospitals, 2015 - 2023 (USD Billion)
  • 7.3. Private Clinics
    • 7.3.1. Global Monoclonal Antibody Therapeutics Market for Private Clinics, 2015 - 2023 (USD Billion)
  • 7.4. Research Institutes
    • 7.4.1. Global Monoclonal Antibody Therapeutics Market for Research Institutes, 2015 - 2023 (USD Billion)

Chapter 8. Global Monoclonal Antibody Therapeutics Market- Regional Segment Analysis

  • 8.1. Global Monoclonal Antibody Therapeutics Market: Regional Overview
    • 8.1.1. Global Monoclonal Antibody Therapeutics Market Revenue Share, by Region, 2017 And 2023
  • 8.2. North America
    • 8.2.1. North America Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
    • 8.2.2. North America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
    • 8.2.3. North America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
    • 8.2.4. North America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
    • 8.2.5. U.S.
      • 8.2.5.1. U.S. Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
      • 8.2.5.2. U.S. Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
      • 8.2.5.3. U.S. Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
    • 8.2.6. Rest of North America
      • 8.2.6.1. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
      • 8.2.6.2. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
      • 8.2.6.3. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
  • 8.3. Europe
    • 8.3.1. Europe Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
    • 8.3.2. Europe Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
    • 8.3.3. Europe Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
    • 8.3.4. Europe Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
    • 8.3.5. UK
      • 8.3.5.1. UK Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
      • 8.3.5.2. UK Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
      • 8.3.5.3. UK Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
    • 8.3.6. Germany
      • 8.3.6.1. Germany Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
      • 8.3.6.2. Germany Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
      • 8.3.6.3. Germany Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
    • 8.3.7. France
      • 8.3.7.1. France Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
      • 8.3.7.2. France Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
      • 8.3.7.3. France Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
    • 8.3.8. Rest of Europe
      • 8.3.8.1. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
      • 8.3.8.2. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
      • 8.3.8.3. Rest of Europe Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
    • 8.4.2. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
    • 8.4.3. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
    • 8.4.4. Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
    • 8.4.5. China
      • 8.4.5.1. China Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
      • 8.4.5.2. China Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
      • 8.4.5.3. China Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
    • 8.4.6. Japan
      • 8.4.6.1. Japan Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
      • 8.4.6.2. Japan Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
      • 8.4.6.3. Japan Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
    • 8.4.7. India
      • 8.4.7.1. India Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
      • 8.4.7.2. India Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
      • 8.4.7.3. India Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
    • 8.4.8. Rest of Asia Pacific
      • 8.4.8.1. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
      • 8.4.8.2. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
      • 8.4.8.3. Rest of Asia Pacific Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
  • 8.5. Latin America
    • 8.5.1. Latin America Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
    • 8.5.2. Latin America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
    • 8.5.3. Latin America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
    • 8.5.4. Rest of North America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
    • 8.5.5. Brazil
      • 8.5.5.1. Brazil Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
      • 8.5.5.2. Brazil Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
      • 8.5.5.3. Brazil Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
    • 8.5.6. Rest of Latin America
      • 8.5.6.1. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
      • 8.5.6.2. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
      • 8.5.6.3. Rest of Latin America Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Monoclonal Antibody Therapeutics Market, 2015 - 2023 (USD Billion)
    • 8.6.2. Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by Application, 2015 - 2023 (USD Billion)
    • 8.6.3. Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by Source, 2015 - 2023 (USD Billion)
    • 8.6.4. Middle East and Africa Monoclonal Antibody Therapeutics Market Revenue, by End User, 2015 - 2023 (USD Billion)

Chapter 9. Company Profile

  • 9.1. Pfizer Inc.
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Product Portfolio
    • 9.1.4. Business Strategy
    • 9.1.5. Recent Developments
  • 9.2. Bayer AG
    • 9.2.1. Overview
    • 9.2.2. Financials
    • 9.2.3. Product Portfolio
    • 9.2.4. Business Strategy
    • 9.2.5. Recent Developments
  • 9.3. Sanofi
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Product Portfolio
    • 9.3.4. Business Strategy
    • 9.3.5. Recent Developments
  • 9.4. Merck Co., Inc.
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Product Portfolio
    • 9.4.4. Business Strategy
    • 9.4.5. Recent Developments
  • 9.5. GlaxoSmithKline Plc.
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Product Portfolio
    • 9.5.4. Business Strategy
    • 9.5.5. Recent Developments
  • 9.6. F. Hoffmann-La Roche Ltd.
    • 9.6.1. Overview
    • 9.6.2. Financials
    • 9.6.3. Product Portfolio
    • 9.6.4. Business Strategy
    • 9.6.5. Recent Developments
  • 9.7. Novartis AG
    • 9.7.1. Overview
    • 9.7.2. Financials
    • 9.7.3. Product Portfolio
    • 9.7.4. Business Strategy
    • 9.7.5. Recent Developments
  • 9.8. Holdings AbbVie Inc.
    • 9.8.1. Overview
    • 9.8.2. Financials
    • 9.8.3. Product Portfolio
    • 9.8.4. Business Strategy
    • 9.8.5. Recent Developments
Back to Top